Aryx Therapeutics Accounts Payable

Aryx Therapeutics (ARYX) currently reports a accounts payable of $230K as of September 2010. That compares with $1.1M in the prior-year period — down 78.7% year over year. Use the charts on this page to explore Aryx Therapeutics's accounts payable history and peer comparisons.

Aryx Therapeutics's accounts payable decreased from $1.1M to $230K — a 78.7% year-over-year decrease (period ending September 2010). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aryx Therapeutics reported $230K in accounts payable as of September 2010. That compares with $1.1M in the prior-year period — down 78.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $230K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aryx Therapeutics, and consider following ARYX for alerts when major investors trade the stock.

Aryx Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $230K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARYX with unrelated industries.